United Services Automobile Association Astrazeneca PLC Transaction History

United Services Automobile Association

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $1.75 Million - $2.24 Million	-40,502 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $41,153 - $55,898	-1,089 Reduced 2.62%	40,502 $1.81 Million
Q4 2019 Jan 14, 2020	SELL	$42.46 - $50.46 $322,356 - $383,092	-7,592 Reduced 15.44%	41,591 $2.07 Million
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $24.8 Million - $28.1 Million	-617,752 Reduced 92.63%	49,183 $2.19 Million
Q2 2019 Aug 16, 2019	SELL	$37.28 - $41.68 $1.49 Million - $1.67 Million	-40,085 Reduced 5.67%	666,935 $27.5 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $1.65 Million - $2 Million	-46,477 Reduced 6.17%	707,020 $28.6 Million
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $1.78 Million - $2.01 Million	-48,377 Reduced 6.03%	753,497 $28.6 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $119,574 - $136,636	-3,440 Reduced 0.43%	801,874 $31.7 Million
Q2 2018 Sep 27, 2018	BUY	$34.55 - $37.05 $24.1 Million - $25.8 Million	697,340 Added 645.84%	805,314 $28.3 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $24.6 Million - $26.4 Million	-713,033 Reduced 86.85%	107,974 $8.8 Million
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $7.19 Million - $7.99 Million	218,075 Added 36.17%	821,007 $28.7 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $2.88 Million - $3.13 Million	89,877 Added 17.52%	602,932 $20.9 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $14.9 Million - $17.4 Million	513,055	513,055 $17.4 Million

1,380

476M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $209B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.